Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 UNLEASHING THE FULL POTENTIAL OF PSILOCYBIN Tryp differs from other psychedelic drug development companies in four important ways: 5 Unique, highly valuable indications While mental health indications such as depression, anxiety, and addiction are being pursued by multiple companies, Tryp is breaking new ground in chronic pain and eating disorders. Taken together, the commercial potential of our development programs exceeds $12 billion in peak annual sales. 01